Malignant How Bad Policy and Bad Evidence Harm People with Cancer
Afbeeldingen
Sla de afbeeldingen overArtikel vergelijken
- Engels
- Hardcover
- 9781421437637
- 21 april 2020
- 304 pagina's
Samenvatting
How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective.
Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel—but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which
• promote novel cancer therapies long before credible data are available to support such treatment; and
• exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars.
Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration.
This is a book about how the actions of human beings—our policies, our standards of evidence, and our drug regulation—incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says,
• more cancer clinical trials should measure outcomes that actually matter to people with cancer;
• patients on those trials should look more like actual global citizens;
• we need drug regulators to raise, not perpetually lower, the bar for approval; and
• we need unbiased patient advocates and experts.
This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer—and how we can avoid repeating the policy and practice mistakes of the past.
Productspecificaties
Inhoud
- Taal
- en
- Bindwijze
- Hardcover
- Oorspronkelijke releasedatum
- 21 april 2020
- Aantal pagina's
- 304
- Illustraties
- Nee
Betrokkenen
- Hoofdauteur
- Vinayak K. Prasad
- Hoofduitgeverij
- Johns Hopkins University Press
Overige kenmerken
- Editie
- 1
- Extra groot lettertype
- Nee
- Product breedte
- 152 mm
- Product hoogte
- 25 mm
- Product lengte
- 229 mm
- Studieboek
- Ja
- Verpakking breedte
- 154 mm
- Verpakking hoogte
- 29 mm
- Verpakking lengte
- 234 mm
- Verpakkingsgewicht
- 870 g
EAN
- EAN
- 9781421437637
Je vindt dit artikel in
- Categorieën
- Taal
- Engels
- Beschikbaarheid
- Leverbaar
- Studieboek of algemeen
- Studieboeken
- Select-bezorgopties
- Vandaag Bezorgd, Avondbezorging, Zondagbezorging, Gratis verzending
Kies gewenste uitvoering
Prijsinformatie en bestellen
De prijs van dit product is 31 euro en 99 cent.- Prijs inclusief verzendkosten, verstuurd door bol
- Ophalen bij een bol afhaalpunt mogelijk
- 30 dagen bedenktijd en gratis retourneren
- Dag en nacht klantenservice
- Vandaag nog in huis (bestel ma-vr voor 12:00, bezorging tussen 17:00 en 22:00)
- Doordeweeks ook ’s avonds in huis
- Ook zondag in huis (bestel voor za 23:59)
Anderen bekeken ook
Vaak samen gekocht
Rapporteer dit artikel
Je wilt melding doen van illegale inhoud over dit artikel:
- Ik wil melding doen als klant
- Ik wil melding doen als autoriteit of trusted flagger
- Ik wil melding doen als partner
- Ik wil melding doen als merkhouder
Geen klant, autoriteit, trusted flagger, merkhouder of partner? Gebruik dan onderstaande link om melding te doen.